Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

13,034

rulemaking dockets

4,738

open for public comment

You can weigh in on these right now

Showing 30 of 13,034 dockets

Nonrulemaking

ATSDR

ATSDR-2026-0001

HHS Requests Public Nominations for Substances Needing Health Risk Profiles

1 doc6 comments

Nonrulemaking

FAA

Open for Comments

FAA-2026-6073

Eliana Starr Reichgott - Exemption/Rulemaking

1 docNo comments

Nonrulemaking

FAA

Open for Comments

FAA-2026-3999

Raytheon - Exemption/Rulemaking

2 docsNo comments

Nonrulemaking

FDA

FDA-2025-H-6229

DAB Civil Money Penalty; Three Limes LLC d/b/a The Bottle Shoppe; CLOSED 05/21/2026

1 docNo comments

Rulemaking

FAA

FAA-2026-3474

FAA proposes tougher maintenance rules for Pilatus PC‑6 planes to prevent structural failures

2 docs2 comments

Rulemaking

FAA

FAA-2026-0025

FAA issues safety rule requiring inspections of brake pedal parts on Leonardo AB139, AW139, AW189 helicopters

6 docsNo comments

Rulemaking

FAA

FAA-2026-0736

FAA Orders Inspections and Fixes for Certain Bell 407 Helicopters After Wire Chafing Risk Found

4 docsNo comments

Nonrulemaking

NRC

NRC-2025-1007

NRC Seeks Public Comment on Draft Environmental Review for Proposed Paducah Uranium Enrichment Plant

2 docs29 comments

Nonrulemaking

FDA

FDA-2026-H-1619

DAB Civil Money Penalty; Kinjan Enterprises Inc. d/b/a Quick Mart; CLOSED 05/21/2026

1 docNo comments

Nonrulemaking

NRC

NRC-2026-0133

NRC Seeks Comment on Updated Rules for Nuclear Plant Training Simulators

1 doc7 comments

Nonrulemaking

NRC

NRC-2026-0760

NRC Seeks Comments on Fast-Track Review Path for Reactors Previously Authorized by DOE or War Department

1 doc56 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2018-0503

EPA Finds Five Phthalates Pose Unreasonable Health or Environmental Risks; Will Begin Risk Management

114 docs60 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2018-0435

Di-isodecyl phthalate (DIDP) (1,2-Benzene- dicarboxylic acid, 1,2- diisodecyl ester); TSCA Review

71 docs6 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2016-0735

HBCD (Hexabromocyclododecane) or Cyclic Aliphatic Bromide Cluster; TSCA Review and Risk Evaluation

46 docs72 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2019-0237

Toxic Substances Control Act (TSCA) Science Advisory Committee on Chemicals (SACC) - Review of Risk Evaluation for Cyclic Aliphatic Bromide Cluster (HBCD)

77 docs49 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2016-0725

Pigment Violet 29 (Anthra[2,1,9-def:6,5,10-d'e'f'] diisoquinoline-1,3,8,10(2H,9H)-tetrone); TSCA Review and Risk Evaluation

34 docs58 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2018-0604

Toxic Substances Control Act (TSCA) Science Advisory Committee on Chemicals (SACC) - Review of Risk Evaluation for Pigment Violet 29 (PV 29)

87 docs49 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2016-0733

Carbon Tetrachloride; TSCA Review and Risk Evaluation

38 docs82 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2019-0499

Toxic Substances Control Act (TSCA) Science Advisory Committee on Chemicals (SAAC) - Review of Risk Evaluation for Carbon Tetrachloride (CCl4, Carbon tet)

47 docs19 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2018-0501

EPA Finds Five Phthalates Pose Unreasonable Health or Environmental Risks; Will Begin Risk Management

119 docs55 comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2021-0254

Asbestos; TSCA Risk Evaluation Part 2: Legacy Uses and Associated Disposals

40 docs72 comments

Nonrulemaking

NOAA

Open for Comments

NOAA-NMFS-2023-0113

NOAA to Study Sites for Gulf of Alaska Aquaculture, Asks Public for Input

6 docs57 comments

Comments due May 29, 2026

Nonrulemaking

EPA

EPA-HQ-OPPT-2019-0501

Toxic Substances Control Act (TSCA) Science Advisory Committee on Chemicals (SACC) - Review of Risk Evaluation for Asbestos

66 docsNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2024-P-1871

Requests the Commissioner to ensure that applications submitted under 505(j) and 505(b)(2) that rely on Lutathera include data necessary to show that a proposed product is pharmaceutically equivalent, bioequivalent, and can be expected to have the same clinical effect and safety profile as Lutathera when administered to patients under the conditions specified in the labeling

12 docs2 comments

Nonrulemaking

FDA

FDA-2026-H-2877

DAB Civil Money Penalty; 8 Eleven Fuel, Inc. d/b/a Shell / Food Mart; CLOSED 05/21/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-3931

DAB Civil Money Penalty; 2199 PDL Petro Inc., d/b/a Sunoco / Food Mart; CLOSED 5/21/2026

1 docNo comments

Nonrulemaking

FAA

Open for Comments

FAA-2026-5710

Little Bohemia Creek Farms LLC - Exemption/Rulemaking

3 docsNo comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2016-0736

Asbestos; TSCA Review and Risk Evaluation

54 docs456 comments

Nonrulemaking

FDA

FDA-2026-H-5714

DAB Civil Money Penalty; Underground Vapes Inc. d/b/a Underground Vapes

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-4733

DAB Civil Money Penalty; Hannibal Sandy's, Inc. d/b/a BP / To Go; CLOSED 5/21/2026

1 docNo comments